Cargando…
New C3H Kit(N824K/WT) cancer mouse model develops late-onset malignant mammary tumors with high penetrance
Gastro-intestinal stromal tumors and acute myeloid leukemia induced by activating stem cell factor receptor tyrosine kinase (KIT) mutations are highly malignant. Less clear is the role of KIT mutations in the context of breast cancer. Treatment success of KIT-induced cancers is still unsatisfactory...
Autores principales: | Klein-Rodewald, Tanja, Micklich, Kateryna, Sanz-Moreno, Adrián, Tost, Monica, Calzada-Wack, Julia, Adler, Thure, Klaften, Matthias, Sabrautzki, Sibylle, Aigner, Bernhard, Kraiger, Markus, Gailus-Durner, Valerie, Fuchs, Helmut, Gründer, Albert, Pahl, Heike, Wolf, Eckhard, Hrabe de Angelis, Martin, Rathkolb, Birgit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671887/ https://www.ncbi.nlm.nih.gov/pubmed/36396684 http://dx.doi.org/10.1038/s41598-022-23218-5 |
Ejemplares similares
-
Monitoring longitudinal disease progression in a novel murine Kit tumor model using high-field MRI
por: Kraiger, Markus, et al.
Publicado: (2022) -
Standardized, systemic phenotypic analysis reveals kidney dysfunction as main alteration of Kctd1(I27N) mutant mice
por: Kumar, Sudhir, et al.
Publicado: (2017) -
New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis
por: Sabrautzki, Sibylle, et al.
Publicado: (2012) -
Erratum to: New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis
por: Sabrautzki, Sibylle, et al.
Publicado: (2014) -
Standardized, Systemic Phenotypic Analysis of Umod
(C93F) and Umod
(A227T) Mutant Mice
por: Kemter, Elisabeth, et al.
Publicado: (2013)